Kamol Pataradool - Gynecology

Author Information

Kamol Pataradool is affiliated with the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand. His research primarily focuses on various aspects of gynecologic oncology, including cervical cancer, endometrial cancer, and ovarian cancer.

Research Contributions

Kamol Pataradool has made significant contributions to the field of gynecologic oncology through his extensive research. His studies have explored topics such as the efficacy of the modified Swede Colposcopic Index in predicting high-grade cervical lesions and cancer, clinical presentations and treatment outcomes of uterine sarcoma, and knowledge and attitudes towards HPV and cervical cancer screening among women in Bangkok. His work has been instrumental in improving understanding and treatment of gynecologic cancers in Thailand.

Aliases

Kamol Pataradool is also known by the aliases K Pataradool and K. Pataradool.

Publication and Citation Metrics

Metric	Value
Total Papers	21
Total Citations	205
H-Index	8

Publications:

The efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervix

DOI: 10.3802/jgo.2019.30.e78

Year: 2019

Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.

DOI: 10.7314/APJCP.2016.17.4.1759

Year: 2016

Knowledge and Attitudes of Bangkok Metropolitan Women towards HPV and Self-Sampled HPV Testing.

DOI:

Year: 2016

Knowledge, Attitudes and Behavior of Bangkok Metropolitan Women Regarding Cervical Cancer Screening.

DOI: 10.7314/APJCP.2016.17.3.945

Year: 2016

Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.

DOI:

Year: 2016

Prevalence and risk factors for positive surgical margin after Loop Electrosurgical Excision Procedure (LEEP) in patients with high grade squamous intraepithelial lesion

DOI:

Year: 2015

Patterns of Adjuvant Therapy for Endometrial Cancer: Single Institutional Experience in Thailand

DOI: 10.1097/IGC.0000000000000391

Year: 2015

Treatment outcomes of gemcitabine in refractory or recurrent epithelial ovarian cancer patients.

DOI: 10.7314/APJCP.2014.15.13.5215

Year: 2014

Endometrial carcinoma: clinical characteristic and survival rates by the new compared to the prior FIGO staging systems.

DOI:

Year: 2013

Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand.

DOI: 10.7314/APJCP.2013.14.4.2421

Year: 2013

What are the Symptoms of Stage 1?

How to Check Eligibility?

How does obesity influence gynecological health?

What Causes Pelvic Girdle Pain?

What Are Gynecology Medical Conferences?

Can Exercise Improve Fertility?

What Are Common Conditions Associated with Pigment Migration?

How is Prophylactic Cerclage Performed?

How to Use Boric Acid Suppositories?

What Are the Screening Guidelines for Osteoporosis?

Partnered Content Networks

Relevant Topics